![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
TELO Telomir Pharmaceuticals
- 4.290
- +0.020+0.47%
Close Feb 14 16:00 ET
- 4.110
- -0.180-4.20%
Post 17:29 ET
127.68MMarket Cap-7.73P/E (TTM)
4.300High4.170Low55.48KVolume4.270Open4.270Pre Close236.50KTurnover0.32%Turnover RatioLossP/E (Static)29.76MShares11.20152wk High195.00P/B74.92MFloat Cap3.11052wk Low--Dividend TTM17.46MShs Float20.720Historical High--Div YieldTTM3.04%Amplitude3.110Historical Low4.262Avg Price1Lot Size
Telomir Pharmaceuticals Stock Forum
Sign in to post a comment
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you do...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you do...
36
6
5
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEV...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEV...
39
15
5
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you ...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you ...
63
25
9
$Telomir Pharmaceuticals (TELO.US)$
Telomir touts potential of Telomir-1 in addressing oxidative stress
Telomir Pharmaceuticals (NASDAQ:TELO) on Tuesday announced results from recent preclinical studies demonstrating the ability of Telomir-1 to fully reverse oxidative stress in human cell lines.
Telomir 1, a novel small molecule metal ion regulator, is under investigation to potentially provide a therapeuticintervention against age-related inflammatory conditions.
Results from its recent preclinical studiesconducted ...
Telomir touts potential of Telomir-1 in addressing oxidative stress
Telomir Pharmaceuticals (NASDAQ:TELO) on Tuesday announced results from recent preclinical studies demonstrating the ability of Telomir-1 to fully reverse oxidative stress in human cell lines.
Telomir 1, a novel small molecule metal ion regulator, is under investigation to potentially provide a therapeuticintervention against age-related inflammatory conditions.
Results from its recent preclinical studiesconducted ...
2
$Telomir Pharmaceuticals (TELO.US)$ Reuters· just
Telomir Pharmaceuticals Inc - Announces Breakthrough Results With Telomir-1
Telomir Pharmaceuticals Inc - Telomir-1 Reverses Copper-Induced Ros Elevation in Human Cell Lines
Telomir Pharmaceuticals Inc - Announces Breakthrough Results With Telomir-1
Telomir Pharmaceuticals Inc - Telomir-1 Reverses Copper-Induced Ros Elevation in Human Cell Lines
$Telomir Pharmaceuticals (TELO.US)$
From an investment perspective, these preclinical results substantially enhance TELO's value proposition. With a market cap of just $135M, the company appears undervalued given the broad therapeutic potential of Telomir-1. The addressable market spans rare diseases like progeria (~400 patients globally) to massive markets like Type 2 diabetes, creating a compelling risk-reward profile.
The metal ion regulation mechanism is particularly...
From an investment perspective, these preclinical results substantially enhance TELO's value proposition. With a market cap of just $135M, the company appears undervalued given the broad therapeutic potential of Telomir-1. The addressable market spans rare diseases like progeria (~400 patients globally) to massive markets like Type 2 diabetes, creating a compelling risk-reward profile.
The metal ion regulation mechanism is particularly...
4
NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release
7. Remember, some stocks may get pumped WITHOUT any catalyst
8. NEVER be a blind follower.
LASTLY, If y...
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release
7. Remember, some stocks may get pumped WITHOUT any catalyst
8. NEVER be a blind follower.
LASTLY, If y...
55
34
12
$Telomir Pharmaceuticals (TELO.US)$
From an investment perspective, these preclinical results substantially enhance TELO's value proposition. With a market cap of just $135M, the company appears undervalued given the broad therapeutic potential of Telomir-1. The addressable market spans rare diseases like progeria (~400 patients globally) to massive markets like Type 2 diabetes, creating a compelling risk-reward profile.
The metal ion regulation mechanism is particular...
From an investment perspective, these preclinical results substantially enhance TELO's value proposition. With a market cap of just $135M, the company appears undervalued given the broad therapeutic potential of Telomir-1. The addressable market spans rare diseases like progeria (~400 patients globally) to massive markets like Type 2 diabetes, creating a compelling risk-reward profile.
The metal ion regulation mechanism is particular...
3
$Telomir Pharmaceuticals (TELO.US)$
The preclinical study results for Telomir-1 represent a significant scientific breakthrough in addressing accelerated aging conditions. The restoration of lifespan in wrn-1-mutated C. elegans to normal levels demonstrates robust proof-of-concept for Telomir-1's mechanism of action. The normalization of physiological parameters like movement velocity provides tangible evidence of improved healthspan, not just lifespan.
The comp...
The preclinical study results for Telomir-1 represent a significant scientific breakthrough in addressing accelerated aging conditions. The restoration of lifespan in wrn-1-mutated C. elegans to normal levels demonstrates robust proof-of-concept for Telomir-1's mechanism of action. The normalization of physiological parameters like movement velocity provides tangible evidence of improved healthspan, not just lifespan.
The comp...
$Telomir Pharmaceuticals (TELO.US)$
Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
Tuesday, 7th January at 8:00 am
MIAMI, FL / ACCESSWIRE / January 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) ("Telomir"), an emerging leader in age-reversal science focused on treating the root causes of diseases rather than just their symptoms, announced today potentially grou...
Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
Tuesday, 7th January at 8:00 am
MIAMI, FL / ACCESSWIRE / January 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) ("Telomir"), an emerging leader in age-reversal science focused on treating the root causes of diseases rather than just their symptoms, announced today potentially grou...
No comment yet
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025
Golden Goose : How do you think Trumps new tarrifs on Canada will affect FMST?
Lynn953818 : thank you very much
Jaguar8 OP Golden Goose : Since the U.S. imports lithium from Canada, any tariffs imposed would likely be reflected in one of two ways: either the cost is added to the price of lithium when it leaves Canada, or U.S. companies importing it will absorb the expense. While tariffs generate revenue for the government, the added costs will ultimately trickle down to consumer goods in the U.S. It’s important to note that Canada supplies 56% of the lithium used in the U.S. This means products that rely on lithium—such as batteries and certain pharmaceuticals—could see price increases if tariffs are applied.
Golden Goose Jaguar8 OP : thanks dude
TerryJinn : QSI, please give me a little push
View more comments...